researcherstaffcancer-centerfemaleno/assets/MGH/images/cancer-center/core/staff/tamryn-gray-120x120.jpgTamryn GrayTamrynGrayPhD, RN/sites/MGH/cancer-center/clinical-trials-and-research/cancer-outcomes-research/team/tamryn-gray.pageFellow, Cancer Outcomes Research and Education Program
Tamryn Gray, PhD, RN
Tamryn Gray, PhD, RN
Fellow, Cancer Outcomes Research and Education Program
About Tamryn Gray, PhD, RN
Tamryn Gray is a postdoctoral research fellow at Dana-Farber Cancer Institute within the Department of Psychosocial Oncology and Palliative Care. She earned her undergraduate and MSN degrees from the University of North Carolina at Chapel Hill and her Ph.D. from Johns Hopkins University. Dr. Gray has published peer-reviewed articles and co-authored book chapters on topics related to solid tumors, hematologic malignancies with a special emphasis on patients undergoing hematopoietic stem cell transplantation, and family caregivers of people with cancer. She has received predoctoral and postdoctoral fellowships from the Robert Wood Johnson Foundation and is a current Hospice and Palliative Nurses Association Research Scholar. She also serves as the Co-Chair for the Caregiver Special Interest Group within the American Psychosocial Oncology Society. Her clinical expertise is hematology/oncology and blood and marrow transplantation, and she spent several years practicing in these areas at Duke University Hospital. Dr. Gray is the recipient of grant funding from the Oncology Nursing Foundation and the American Cancer Society, and her dissertation study examined the role of decision partners in clinical trial decision-making for adults with cancer. Dr. Gray is currently completing her MPH at Harvard T.H. Chan School of Public Health with a focus in Clinical and Social Epidemiology.
Dr. Gray’s research interests include patient-family centered care, disparities, decision science and health services research. Currently, Dr Gray’s research focuses on the needs of family caregivers who are most vulnerable to caregiver burden and poor quality of life when caring for individuals with advanced cancer. She seeks to develop and test innovative, supportive care interventions to improve outcomes of patients and their family caregivers.